Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

[Treatment of renal anemia in hemodialysis patients in General Hospital Bjelovar from 2007 to 2010].

Lovcić V, Vujić J, Basić-Jukić N, Kurtović I, Janković RI, Lovcić P, Dzapo M.

Acta Med Croatica. 2011 Oct;65 Suppl 3:49-53. Croatian.

PMID:
23120816
2.

[Treatment of renal anemia with iron in hemodialysis patients in General Hospital Bjelovar].

Lovcić V, Vujić J, Basić-Jukić N, Janković RI, Kurtović I, Dzapo M, Lovcić P.

Acta Med Croatica. 2011 Oct;65 Suppl 3:45-8. Croatian.

PMID:
23120815
3.

2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.

Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.

Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.

PMID:
20609178
4.

[Opatija study: observation of hemodialysis patients and titration of CERA dose just switched from another erythropoiesis stimulating agent].

Jelić I, Lovcić V, Kurtović I, Josipović M, Havranek Z, Kostić L, Racki S.

Acta Med Croatica. 2012 Jul;66(3):157-64. Croatian.

PMID:
23441529
5.

Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.

Bárány P, Clyne N, Hylander B, Johansson AC, Simonsen O, Larsson R, Frisenette-Fich C, Svensson B, Helmers C.

Perit Dial Int. 1995;15(1):54-60.

PMID:
7734561
6.

Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.

Collins AJ, Monda KL, Molony JT, Li S, Gilbertson DT, Bradbury BD.

Am J Kidney Dis. 2014 Jun;63(6):997-1006. doi: 10.1053/j.ajkd.2013.10.052. Epub 2013 Dec 4.

PMID:
24315770
7.

[Anemia in peritoneal dialysis patients].

Lausević M, Nesić V, Jovanović N, Stojimirović B.

Srp Arh Celok Lek. 2006 Mar-Apr;134(3-4):133-7. Serbian.

8.

Epoetin-beta (Recormon-Roche) in the treatment of renal anemia in patients with chronic renal failure.

Tilkian EE, Tzekov VD, Pandeva SM, Kumchev EP, Nikolov DG, Dimitrakov JD, Dimitrakov DD.

Folia Med (Plovdiv). 2000;42(3):11-5.

PMID:
11347329
9.

Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.

Attallah N, Osman-Malik Y, Frinak S, Besarab A.

Am J Kidney Dis. 2006 Apr;47(4):644-54.

PMID:
16564942
11.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

Madore F, Lowrie EG, Brugnara C, Lew NL, Lazarus JM, Bridges K, Owen WF.

J Am Soc Nephrol. 1997 Dec;8(12):1921-9.

12.
13.

Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.

McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ.

Am J Nephrol. 2000 Nov-Dec;20(6):455-62.

PMID:
11146312
14.

[Erythropoietin and transfusions in patients with anemia of chronic renal failure origin : an update view].

Duclos J, Olea C, Aguirre H, Alvarez MC, Salgado MC.

Rev Med Chil. 1995 Apr;123(4):451-5. Spanish.

PMID:
8525189
15.

[Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].

Jalil R, Vaccarezza A, Jara A, Lira P, Vial S, Serrano V.

Rev Med Chil. 1990 Jun;118(6):629-34. Spanish.

PMID:
1775783
16.

Anemia in dialysis: its relation to acquired cystic kidney disease and serum levels of erythropoietin.

Férnandez A, Hortal L, Rodríguez JC, Vega N, Plaza C, Palop L.

Am J Nephrol. 1991;11(1):12-5.

PMID:
2048573
17.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.

Clin Nephrol. 2001 Mar;55(3):212-9.

PMID:
11316241
18.

The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.

Provenzano R, Besarab A, Macdougall IC, Ellison DH, Maxwell AP, Sulowicz W, Klinger M, Rutkowski B, Correa-Rotter R, Dougherty FC; BA 16528 Study Investigators..

Clin Nephrol. 2007 May;67(5):306-17.

PMID:
17542340
19.
20.

Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.

Canaud B, Polito-Bouloux C, Garred LJ, Rivory JP, Donnadieu P, Taib J, Florence P, Mion C.

Am J Kidney Dis. 1990 Feb;15(2):169-75.

PMID:
2301388

Supplemental Content

Support Center